应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ZVSA ZYVERSA THERAPEUTICS INC
交易中 07-16 13:29:46 EDT
0.3326
-0.2164
-39.42%
最高
0.5550
最低
0.3100
成交量
485.90万
今开
0.5500
昨收
0.5490
日振幅
44.63%
总市值
162.09万
流通市值
120.19万
总股本
487.35万
成交额
181.13万
换手率
134.47%
流通股本
361.35万
市净率
0.20
ROE
-91.39%
每股收益
-8.48
52周最高
5.22
52周最低
0.3100
市盈率
-0.04
股息
0.00
股息收益率
0.00
ROA
-24.79%
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Zyversa Therapeutics, Inc.盘中异动 早盘急速下跌5.26%
市场透视 · 14:05
Zyversa Therapeutics, Inc.盘中异动 早盘急速下跌5.26%
Zyversa Therapeutics, Inc.盘中异动 早盘快速下挫6.13%报0.533美元
市场透视 · 07-15 13:43
Zyversa Therapeutics, Inc.盘中异动 早盘快速下挫6.13%报0.533美元
Zyversa Therapeutics, Inc.盘中异动 股价大跌6.08%
市场透视 · 07-14 13:33
Zyversa Therapeutics, Inc.盘中异动 股价大跌6.08%
Zyversa Therapeutics, Inc.盘中异动 股价大跌5.03%报0.560美元
市场透视 · 07-11
Zyversa Therapeutics, Inc.盘中异动 股价大跌5.03%报0.560美元
Zyversa Therapeutics, Inc.股价重挫12.20% 市值跌33.4万美元
市场透视 · 07-10
Zyversa Therapeutics, Inc.股价重挫12.20% 市值跌33.4万美元
Zyversa Therapeutics, Inc.7月8日成交额为2.41亿美元
市场透视 · 07-09
Zyversa Therapeutics, Inc.7月8日成交额为2.41亿美元
Zyversa Therapeutics, Inc.2025财年第一财季实现净利润-2.26百万美元,同比增加20.14%
市场透视 · 05-18
Zyversa Therapeutics, Inc.2025财年第一财季实现净利润-2.26百万美元,同比增加20.14%
Zyversa Therapeutics, Inc.5月8日成交额为113.29万美元
市场透视 · 05-09
Zyversa Therapeutics, Inc.5月8日成交额为113.29万美元
Zyversa Therapeutics, Inc.5月7日成交额为4792.37万美元
市场透视 · 05-08
Zyversa Therapeutics, Inc.5月7日成交额为4792.37万美元
Zyversa Therapeutics, Inc.5月6日成交额为15.68万美元
市场透视 · 05-07
Zyversa Therapeutics, Inc.5月6日成交额为15.68万美元
Zyversa Therapeutics, Inc.5月2日成交额为9.52万美元
市场透视 · 05-03
Zyversa Therapeutics, Inc.5月2日成交额为9.52万美元
Zyversa Therapeutics, Inc.4月30日成交额为18.61万美元
市场透视 · 05-01
Zyversa Therapeutics, Inc.4月30日成交额为18.61万美元
Zyversa Therapeutics, Inc.4月29日成交额为419.74万美元
市场透视 · 04-30
Zyversa Therapeutics, Inc.4月29日成交额为419.74万美元
Zyversa Therapeutics, Inc.4月28日成交额为5.39万美元
市场透视 · 04-29
Zyversa Therapeutics, Inc.4月28日成交额为5.39万美元
Zyversa Therapeutics, Inc.4月24日成交额为13.43万美元
市场透视 · 04-25
Zyversa Therapeutics, Inc.4月24日成交额为13.43万美元
Zyversa Therapeutics, Inc.4月22日成交额为12.64万美元
市场透视 · 04-23
Zyversa Therapeutics, Inc.4月22日成交额为12.64万美元
Zyversa Therapeutics, Inc.4月17日成交额为8.80万美元
市场透视 · 04-18
Zyversa Therapeutics, Inc.4月17日成交额为8.80万美元
Zyversa Therapeutics, Inc.盘中异动 早盘快速跳水5.40%
市场透视 · 04-16
Zyversa Therapeutics, Inc.盘中异动 早盘快速跳水5.40%
Zyversa Therapeutics, Inc.4月14日成交额为646.36万美元
市场透视 · 04-15
Zyversa Therapeutics, Inc.4月14日成交额为646.36万美元
Zyversa Therapeutics, Inc.盘中异动 股价大跌7.77%
市场透视 · 04-14
Zyversa Therapeutics, Inc.盘中异动 股价大跌7.77%
加载更多
公司概况
公司名称:
ZYVERSA THERAPEUTICS INC
所属市场:
NASDAQ
上市日期:
--
主营业务:
ZyVersa Therapeutics, Inc.于2021年3月17日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,利用专有技术为具有高度未满足医疗需求的慢性肾病或炎症性疾病患者开发药物。
发行价格:
--
{"stockData":{"symbol":"ZVSA","market":"US","secType":"STK","nameCN":"ZYVERSA THERAPEUTICS INC","latestPrice":0.33,"timestamp":1752686982729,"preClose":0.549,"halted":0,"volume":4857033,"delay":0,"floatShares":3613500,"shares":4873463,"eps":-8.480319,"marketStatus":"交易中","change":-0.219,"latestTime":"07-16 13:29:42 EDT","open":0.55,"high":0.555,"low":0.31,"amount":1810678.83149325,"amplitude":0.446266,"askPrice":0.3327,"askSize":100,"bidPrice":0.33,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-8.480319,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752696000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.549,"preHourTrading":{"tag":"盘前","latestPrice":0.5331,"preClose":0.549,"latestTime":"09:27 EDT","volume":15774,"amount":8563.8923106,"timestamp":1752672442944},"postHourTrading":{"tag":"盘后","latestPrice":0.54,"preClose":0.549,"latestTime":"19:43 EDT","volume":4610,"amount":2507.6719,"timestamp":1752623026548},"volumeRatio":4.738358},"requestUrl":"/m/hq/s/ZVSA","defaultTab":"news","newsList":[{"id":"2552121074","title":"Zyversa Therapeutics, Inc.盘中异动 早盘急速下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552121074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552121074?lang=zh_cn&edition=full","pubTime":"2025-07-16 22:05","pubTimestamp":1752674738,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日22时05分,Zyversa Therapeutics, Inc.股票出现异动,股价大幅下挫5.26%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.76%。Zyversa Therapeutics, Inc.公司简介:ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071622053997a88b38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071622053997a88b38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ZVSA","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2551319325","title":"Zyversa Therapeutics, Inc.盘中异动 早盘快速下挫6.13%报0.533美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551319325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551319325?lang=zh_cn&edition=full","pubTime":"2025-07-15 21:43","pubTimestamp":1752587003,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日21时43分,Zyversa Therapeutics, Inc.股票出现波动,股价急速下跌6.13%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.03%。其相关个股中,Kairos Pharma, Ltd.、Cyclacel Pharmaceuticals, Inc.、Polyrizon Ltd.涨幅较大,60 Degrees Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.较为活跃,换手率分别为1389.07%、792.37%、539.23%,振幅较大的相关个股有Kairos Pharma, Ltd.、Cyclacel Pharmaceuticals, Inc.、Polyrizon Ltd.,振幅分别为74.44%、63.75%、53.51%。Zyversa Therapeutics, Inc.公司简介:ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715214323a6ab5a53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715214323a6ab5a53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","LENZ","ZVSA"],"gpt_icon":0},{"id":"2551180946","title":"Zyversa Therapeutics, Inc.盘中异动 股价大跌6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551180946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551180946?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:33","pubTimestamp":1752499981,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时33分,Zyversa Therapeutics, Inc.股票出现异动,股价大幅跳水6.08%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。其相关个股中,Dare Bioscience, Inc.、Biomx Inc.、Rani Therapeutics Holdings, Inc.涨幅较大,Windtree Therapeutics, Inc.、Dare Bioscience, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为1618.03%、332.84%、170.82%,振幅较大的相关个股有Dare Bioscience, Inc.、Biomx Inc.、Rani Therapeutics Holdings, Inc.,振幅分别为45.33%、44.41%、17.95%。Zyversa Therapeutics, Inc.公司简介:ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213301a6a8f0bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714213301a6a8f0bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","ZVSA","BK4539"],"gpt_icon":0},{"id":"2550954339","title":"Zyversa Therapeutics, Inc.盘中异动 股价大跌5.03%报0.560美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550954339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550954339?lang=zh_cn&edition=full","pubTime":"2025-07-11 22:13","pubTimestamp":1752243231,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日22时13分,Zyversa Therapeutics, Inc.股票出现异动,股价大幅下挫5.03%。截至发稿,该股报0.560美元/股,成交量41.283万股,换手率8.47%,振幅3.25%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.77%。Zyversa Therapeutics, Inc.公司简介:ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711221351a4450f76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711221351a4450f76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","ZVSA","BK4539","BK4139"],"gpt_icon":0},{"id":"2550925625","title":"Zyversa Therapeutics, Inc.股价重挫12.20% 市值跌33.4万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550925625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550925625?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:31","pubTimestamp":1752154285,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时31分,Zyversa Therapeutics, Inc.股票出现波动,股价快速下跌12.20%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.14%。Zyversa Therapeutics, Inc.公司简介:ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213125a442b7ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710213125a442b7ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","ZVSA","LENZ","BK4139"],"gpt_icon":0},{"id":"2550638610","title":"Zyversa Therapeutics, Inc.7月8日成交额为2.41亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550638610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550638610?lang=zh_cn&edition=full","pubTime":"2025-07-09 16:40","pubTimestamp":1752050445,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日,Zyversa Therapeutics, Inc.成交额为2.41亿美元,成交额较昨日增加226244.99%,当日成交量为2.08亿股。Zyversa Therapeutics, Inc.于2025年7月8日涨17.37%,报0.775美元,该股过去5个交易日涨14.48%,年初至今跌26.89%,过去60日跌24.76%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-08|2.41亿|226244.99%|2.08亿|#|2025-07-07|10.64万|17.64%|15.92万|#|2025-07-03|9.05万|-69.70%|13.34万|#|2025-07-02|29.87万|80.47%|43.58万|#|2025-07-01|16.55万|-15.63%|25.17万|ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172954a44008ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709172954a44008ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","BK4539","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2536594380","title":"Zyversa Therapeutics, Inc.2025财年第一财季实现净利润-2.26百万美元,同比增加20.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536594380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536594380?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:01","pubTimestamp":1747584072,"startTime":"0","endTime":"0","summary":"5月19日,Zyversa Therapeutics, Inc.公布财报,公告显示公司2025财年第一财季净利润为-2.26百万美元,同比增加20.14%;其中营业收入为0.00美元,每股基本收益为-0.73美元。从资产负债表来看,Zyversa Therapeutics, Inc.总负债12.86百万美元,其中短期债务0.00美元,资产负债比为1.64,流动比率为0.18。机构评级:截至2025年5月19日,当前有1家机构对Zyversa Therapeutics, Inc.目标价做出预测,其中目标均价为20.00美元,其中最低目标价为20.00美元,最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000423a482f0e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000423a482f0e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","LENZ"],"gpt_icon":0},{"id":"2534614812","title":"Zyversa Therapeutics, Inc.5月8日成交额为113.29万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534614812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534614812?lang=zh_cn&edition=full","pubTime":"2025-05-09 11:47","pubTimestamp":1746762428,"startTime":"0","endTime":"0","summary":"美东时间2025年5月8日,Zyversa Therapeutics, Inc.成交额为113.29万美元,成交额较昨日减少97.64%,当日成交量为187.97万股。Zyversa Therapeutics, Inc.于2025年5月8日跌16.59%,报0.571美元,该股过去5个交易日跌7.72%,年初至今跌46.11%,过去60日跌54.67%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-08|113.29万|-97.64%|187.97万|#|2025-05-07|4792.37万|30467.10%|6690.67万|#|2025-05-06|15.68万|71.49%|26.97万|#|2025-05-05|9.14万|-3.94%|14.80万|#|2025-05-02|9.52万|5.32%|15.39万|ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509114713a4779720&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509114713a4779720&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","BK4539","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2533494554","title":"Zyversa Therapeutics, Inc.5月7日成交额为4792.37万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533494554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533494554?lang=zh_cn&edition=full","pubTime":"2025-05-08 11:31","pubTimestamp":1746675111,"startTime":"0","endTime":"0","summary":"美东时间2025年5月7日,Zyversa Therapeutics, Inc.成交额为4792.37万美元,成交额较昨日增加30467.10%,当日成交量为6690.67万股。Zyversa Therapeutics, Inc.于2025年5月7日涨24.24%,报0.685美元,该股过去5个交易日涨12.26%,年初至今跌35.4%,过去60日跌43.87%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-07|4792.37万|30467.10%|6690.67万|#|2025-05-06|15.68万|71.49%|26.97万|#|2025-05-05|9.14万|-3.94%|14.80万|#|2025-05-02|9.52万|5.32%|15.39万|#|2025-05-01|9.04万|-51.44%|15.06万|ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508113155a6d71781&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508113155a6d71781&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","ZVSA"],"gpt_icon":0},{"id":"2533649401","title":"Zyversa Therapeutics, Inc.5月6日成交额为15.68万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533649401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533649401?lang=zh_cn&edition=full","pubTime":"2025-05-07 11:31","pubTimestamp":1746588699,"startTime":"0","endTime":"0","summary":"美东时间2025年5月6日,Zyversa Therapeutics, Inc.成交额为15.68万美元,成交额较昨日增加71.49%,当日成交量为26.97万股。Zyversa Therapeutics, Inc.于2025年5月6日跌8.45%,报0.551美元,该股过去5个交易日跌17.73%,年初至今跌48.0%,过去60日跌55.19%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-06|15.68万|71.49%|26.97万|#|2025-05-05|9.14万|-3.94%|14.80万|#|2025-05-02|9.52万|5.32%|15.39万|#|2025-05-01|9.04万|-51.44%|15.06万|#|2025-04-30|18.61万|-95.57%|30.28万|ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507113148a474cbe3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507113148a474cbe3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2532883803","title":"Zyversa Therapeutics, Inc.5月2日成交额为9.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532883803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532883803?lang=zh_cn&edition=full","pubTime":"2025-05-03 11:27","pubTimestamp":1746242828,"startTime":"0","endTime":"0","summary":"美东时间2025年5月2日,Zyversa Therapeutics, Inc.成交额为9.52万美元,成交额较昨日增加5.32%,当日成交量为15.39万股。Zyversa Therapeutics, Inc.于2025年5月2日跌1.45%,报0.61美元,该股过去5个交易日跌12.98%,年初至今跌42.45%,过去60日跌52.34%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-02|9.52万|5.32%|15.39万|#|2025-05-01|9.04万|-51.44%|15.06万|#|2025-04-30|18.61万|-95.57%|30.28万|#|2025-04-29|419.74万|7694.12%|650.72万|#|2025-04-28|5.39万|7.64%|7.90万|ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503112717a6d1abff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503112717a6d1abff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ZVSA","BK4139","BK4007"],"gpt_icon":0},{"id":"2532604512","title":"Zyversa Therapeutics, Inc.4月30日成交额为18.61万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532604512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532604512?lang=zh_cn&edition=full","pubTime":"2025-05-01 11:28","pubTimestamp":1746070088,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日,Zyversa Therapeutics, Inc.成交额为18.61万美元,成交额较昨日减少95.57%,当日成交量为30.28万股。Zyversa Therapeutics, Inc.于2025年4月30日跌9.02%,报0.61美元,该股过去5个交易日跌13.86%,年初至今跌42.46%,过去60日跌55.15%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-30|18.61万|-95.57%|30.28万|#|2025-04-29|419.74万|7694.12%|650.72万|#|2025-04-28|5.39万|7.64%|7.90万|#|2025-04-25|5.00万|-62.74%|7.19万|#|2025-04-24|13.43万|61.17%|18.11万|ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501112818a6cf9e11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501112818a6cf9e11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","ZVSA","BK4139"],"gpt_icon":0},{"id":"2531068729","title":"Zyversa Therapeutics, Inc.4月29日成交额为419.74万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531068729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531068729?lang=zh_cn&edition=full","pubTime":"2025-04-30 11:25","pubTimestamp":1745983506,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日,Zyversa Therapeutics, Inc.成交额为419.74万美元,成交额较昨日增加7694.12%,当日成交量为650.72万股。Zyversa Therapeutics, Inc.于2025年4月29日跌0.7%,报0.67美元,该股过去5个交易日涨0.81%,年初至今跌36.75%,过去60日跌51.77%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-29|419.74万|7694.12%|650.72万|#|2025-04-28|5.39万|7.64%|7.90万|#|2025-04-25|5.00万|-62.74%|7.19万|#|2025-04-24|13.43万|61.17%|18.11万|#|2025-04-23|8.33万|-34.08%|11.59万|ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430112512a46d1378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430112512a46d1378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2531245657","title":"Zyversa Therapeutics, Inc.4月28日成交额为5.39万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531245657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531245657?lang=zh_cn&edition=full","pubTime":"2025-04-29 11:21","pubTimestamp":1745896866,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日,Zyversa Therapeutics, Inc.成交额为5.39万美元,成交额较昨日增加7.64%,当日成交量为7.90万股。Zyversa Therapeutics, Inc.于2025年4月28日跌3.69%,报0.675美元,该股过去5个交易日跌3.56%,年初至今跌36.31%,过去60日跌51.08%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-28|5.39万|7.64%|7.90万|#|2025-04-25|5.00万|-62.74%|7.19万|#|2025-04-24|13.43万|61.17%|18.11万|#|2025-04-23|8.33万|-34.08%|11.59万|#|2025-04-22|12.64万|21.97%|18.69万|ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429112111a6cc92cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429112111a6cc92cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","ZVSA"],"gpt_icon":0},{"id":"2530414239","title":"Zyversa Therapeutics, Inc.4月24日成交额为13.43万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530414239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530414239?lang=zh_cn&edition=full","pubTime":"2025-04-25 11:18","pubTimestamp":1745551080,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日,Zyversa Therapeutics, Inc.成交额为13.43万美元,成交额较昨日增加61.17%,当日成交量为18.11万股。Zyversa Therapeutics, Inc.于2025年4月24日涨1.0%,报0.715美元,该股过去5个交易日涨0.29%,年初至今跌32.54%,过去60日跌47.42%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-24|13.43万|61.17%|18.11万|#|2025-04-23|8.33万|-34.08%|11.59万|#|2025-04-22|12.64万|21.97%|18.69万|#|2025-04-21|10.36万|17.76%|14.81万|#|2025-04-17|8.80万|-70.76%|12.30万|ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425111802a6c777fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425111802a6c777fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZVSA","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2529051129","title":"Zyversa Therapeutics, Inc.4月22日成交额为12.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529051129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529051129?lang=zh_cn&edition=full","pubTime":"2025-04-23 11:19","pubTimestamp":1745378372,"startTime":"0","endTime":"0","summary":"美东时间2025年4月22日,Zyversa Therapeutics, Inc.成交额为12.64万美元,成交额较昨日增加21.97%,当日成交量为18.69万股。Zyversa Therapeutics, Inc.于2025年4月22日跌5.0%,报0.665美元,该股过去5个交易日跌21.76%,年初至今跌37.26%,过去60日跌55.07%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-22|12.64万|21.97%|18.69万|#|2025-04-21|10.36万|17.76%|14.81万|#|2025-04-17|8.80万|-70.76%|12.30万|#|2025-04-16|30.10万|-51.49%|42.04万|#|2025-04-15|62.04万|-90.40%|77.44万|ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423111943a6c499ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423111943a6c499ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ZVSA","BK4007"],"gpt_icon":0},{"id":"2528086301","title":"Zyversa Therapeutics, Inc.4月17日成交额为8.80万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528086301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528086301?lang=zh_cn&edition=full","pubTime":"2025-04-18 11:24","pubTimestamp":1744946693,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日,Zyversa Therapeutics, Inc.成交额为8.80万美元,成交额较昨日减少70.76%,当日成交量为12.30万股。Zyversa Therapeutics, Inc.于2025年4月17日跌1.89%,报0.699美元,该股过去5个交易日跌9.33%,年初至今跌34.05%,过去60日跌50.06%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-17|8.80万|-70.76%|12.30万|#|2025-04-16|30.10万|-51.49%|42.04万|#|2025-04-15|62.04万|-90.40%|77.44万|#|2025-04-14|646.36万|836.63%|644.81万|#|2025-04-11|69.01万|-88.73%|78.63万|ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418112456a45d5d79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418112456a45d5d79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","ZVSA"],"gpt_icon":0},{"id":"2527755248","title":"Zyversa Therapeutics, Inc.盘中异动 早盘快速跳水5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527755248","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527755248?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:32","pubTimestamp":1744810345,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时32分,Zyversa Therapeutics, Inc.股票出现异动,股价大幅下挫5.40%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.22%。Zyversa Therapeutics, Inc.公司简介:ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416213225a6bca3b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416213225a6bca3b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ZVSA","BK4007"],"gpt_icon":0},{"id":"2527830244","title":"Zyversa Therapeutics, Inc.4月14日成交额为646.36万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527830244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527830244?lang=zh_cn&edition=full","pubTime":"2025-04-15 11:05","pubTimestamp":1744686321,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日,Zyversa Therapeutics, Inc.成交额为646.36万美元,成交额较昨日增加836.63%,当日成交量为644.81万股。Zyversa Therapeutics, Inc.于2025年4月14日涨10.39%,报0.85美元,该股过去5个交易日涨46.05%,年初至今跌19.81%,过去60日跌37.04%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-14|646.36万|836.63%|644.81万|#|2025-04-11|69.01万|-88.73%|78.63万|#|2025-04-10|612.09万|180.03%|543.84万|#|2025-04-09|218.58万|-98.43%|226.43万|#|2025-04-08|1.39亿|255837.39%|1.14亿|ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415110524a6bab9e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415110524a6bab9e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","ZVSA"],"gpt_icon":0},{"id":"2527193579","title":"Zyversa Therapeutics, Inc.盘中异动 股价大跌7.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527193579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527193579?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:32","pubTimestamp":1744637573,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时32分,Zyversa Therapeutics, Inc.股票出现波动,股价急速跳水7.77%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.63%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Third Harmonic Bio, Inc.、Theratechnologies Inc.涨幅较大,Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃,换手率分别为276.68%、134.20%、86.80%,振幅较大的相关个股有Verrica制药、Neuraxis, Inc.、Artelo Biosciences, Inc.,振幅分别为17.60%、15.64%、13.38%。Zyversa Therapeutics, Inc.公司简介:ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司,利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421325494d50a91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421325494d50a91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","ZVSA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zyversa.com","stockEarnings":[{"period":"1week","weight":-0.2916},{"period":"1month","weight":-0.1582},{"period":"3month","weight":-0.2296},{"period":"6month","weight":-0.5933},{"period":"1year","weight":-0.8755},{"period":"ytd","weight":-0.4821}],"compareEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.0421},{"period":"3month","weight":0.1835},{"period":"6month","weight":0.0516},{"period":"1year","weight":0.1079},{"period":"ytd","weight":0.0615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ZyVersa Therapeutics, Inc.于2021年3月17日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,利用专有技术为具有高度未满足医疗需求的慢性肾病或炎症性疾病患者开发药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.038913},{"month":2,"riseRate":0.666667,"avgChangeRate":0.312769},{"month":3,"riseRate":0.25,"avgChangeRate":-0.21917},{"month":4,"riseRate":0,"avgChangeRate":-0.271187},{"month":5,"riseRate":0.25,"avgChangeRate":-0.062633},{"month":6,"riseRate":0.25,"avgChangeRate":-0.122221},{"month":7,"riseRate":0.25,"avgChangeRate":-0.140827},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.125319},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.072915},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.174582},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.220669},{"month":12,"riseRate":0,"avgChangeRate":-0.487604}],"exchange":"NASDAQ","name":"ZYVERSA THERAPEUTICS INC","nameEN":"ZYVERSA THERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ZYVERSA THERAPEUTICS INC(ZVSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ZYVERSA THERAPEUTICS INC(ZVSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ZYVERSA THERAPEUTICS INC,ZVSA,ZYVERSA THERAPEUTICS INC股票,ZYVERSA THERAPEUTICS INC股票老虎,ZYVERSA THERAPEUTICS INC股票老虎国际,ZYVERSA THERAPEUTICS INC行情,ZYVERSA THERAPEUTICS INC股票行情,ZYVERSA THERAPEUTICS INC股价,ZYVERSA THERAPEUTICS INC股市,ZYVERSA THERAPEUTICS INC股票价格,ZYVERSA THERAPEUTICS INC股票交易,ZYVERSA THERAPEUTICS INC股票购买,ZYVERSA THERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ZYVERSA THERAPEUTICS INC(ZVSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ZYVERSA THERAPEUTICS INC(ZVSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}